Here, it is important to note that, unlike the aforementioned studies carried out over several weeks, our goal was to identify the early targets of activin A and BMP4 in testicular cancer cells to investigate the initial stages of pathway crosstalk, and thus the treatments were short term (≤48 h). This evidence concerns the gene BMP4 and testicular cancer.